Miller M A, Yousuf M, Griffin P S, Bartlett M, Crane J K
Microbiol Immunol. 1979;23(10):955-64. doi: 10.1111/j.1348-0421.1979.tb00526.x.
Synergistic antibiotic studies were undertaken to compare the effectiveness of two new beta-lactamase resistant cephalosporins, cefamandole, and carbenicillin, with four aminoglycosides against clinical strains of Serratia marcescens. The strains demonstrated various combinations of resistance and/or susceptibility to the antibiotics tested. Tobramycin was the most effective aminoglycoside when used in combination with beta-lactam antibiotics. Carbenicillin and cefamandole demonstrated similar activity with aminoglycosides in synergy experiments. Tobramycin-carbenicillin was found to be the superior pairs as indicated by the total number of strains inhibited. This combination was the only one effective against certain high drug resistant strains and the strain resistant to all four aminoglycosides. Carbenicillin or cefamandole with tobramycin exhibited comparable activity against multiple drug resistant organisms. However, mutants significantly more resistant to cefamandole developed during susceptibility testing. The findings of this study have clinical relevance for treating infections by this formidable pathogen.
进行了协同抗生素研究,以比较两种新型耐β-内酰胺酶头孢菌素(头孢孟多和羧苄西林)与四种氨基糖苷类药物对粘质沙雷氏菌临床菌株的有效性。这些菌株对所测试的抗生素表现出不同的耐药性和/或敏感性组合。妥布霉素与β-内酰胺类抗生素联合使用时是最有效的氨基糖苷类药物。在协同实验中,羧苄西林和头孢孟多与氨基糖苷类药物表现出相似的活性。从被抑制菌株的总数来看,妥布霉素-羧苄西林被发现是更优组合。这种组合是唯一对某些高耐药菌株和对所有四种氨基糖苷类药物均耐药的菌株有效的组合。羧苄西林或头孢孟多与妥布霉素对多重耐药菌表现出相当的活性。然而,在药敏试验期间出现了对头孢孟多耐药性明显更高的突变体。本研究的结果对于治疗这种可怕病原体引起的感染具有临床意义。